外科疾病导致的胆源性肝损伤诊治现状

doi:10.3969/j.issn.1672-5069.2021.06.002

Abstract

Tang Lei, Zou Guizhou. Management of patients with biliary liver injury caused by surgical diseases[J]. Journal of Practical Hepatology, 2021, 24(6): 769-771.

[1] Virani S,Akers A,Stephenson K,et al. Comprehensive review of molecular mechanisms during cholestatic liver injury and cholangiocarcinoma. J Liver, 2018, 7(3): 321-325.
[2] Cai SY, Boyer JL. Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury. Inflamm Cell Signal, 2017,4(2):e1561.
[3] Woolbright BL. Inflammation: Cause or consequence of chronic cholestatic liver injury. Food Chem Toxicol,2020,137:111133.
[4] Videhult1 P, Sandblom G.Are liver function tests, pancreatitis and cholecystitis predictors of common bile duct stones? Results of a prospective, population-based, cohort study of 1171 patients undergoing cholecystectomy. Int Hepatopancreatobiliary Ass,2011,13,519-527.
[5] Cai SY, Ge M, Mennone A,et al. Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct-ligated mouse. Cell Mol Gastroenterol Hepatol, 2020, 9(4):679-688.
[6] Rangaswamy R, Singh CG, Singh HM, et al. Impact of biliary calculi on the liver. J Clin Diagn Res, 2017,11(4):4-7.
[7] Lageron A, Levy VG, Saffroy M, et al. Histological and histoenzymological study of liver, in gallstone without treatment. Acta Histochem, 2009,65(1):1-7.
[8] Kakar S, Batts KP, Poterucha JJ, et al. Histologic changes mimicking biliary disease in liver biopsies with venous outflow impairment. J Clin Pathol, 2004,17(7):874-878.
[9] Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers, 2016,2:1-17.
[10] 黄志强. 医源性胆管狭窄:胆道外科之痛.中华消化外科杂志,2015,14(5):23-27.
[11] Geng ZM, Yao YM, Liu QG, et al. Mechanism of benign biliary stricture: a morphological and immunohistochemical study. World J Gastroenterol, 2005, (2):293-295.
[12] Li K, Shi C, Huang J, et al. Dexamethasone effect on the expression of transforming growth factor-β1/Smads signaling pathway in benign biliary stricture fibroblasts in rodent. J Coll Physicians Surg Pak,2017,27(3):131-134.
[13] 王敬. 胆道损伤及损伤性胆管狭窄的外科治疗见解. 中国医刊,2019,54(7):702-704.
[14] Mercado MA, Sanchez N, Urencio M. Major hepatectomy for the treatment of complex bile duct injury. Ann Surg, 2009,249(3):542-543.
[15] Negi SS, Chaudhary A. Analysis of abnormal recovery pattern of liver function tests after surgical repair of bile duct strictures. J Gastroenterol Hepatol, 2005,20(10):1533-1537.
[16] Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet,2009,374: 1704-1713.
[17] Asai A, Miethke A, Bezerra JA. Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol, 2015,12(6):342-352.
[18] A-Kader HH, Abdel-Hameed A, Al-Shabrawi M, et al. Is biliary atresia: an autoimmune disease? Eur J Gastroenterol Hepatol, 2003,15:447.

Management of patients with biliary liver injury caused by surgical diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Li Jingjing, Zou Guizhou. Biliary liver injury: Current state of the art [J]. Journal of Practical Hepatology, 2021, 24(6): 765-768.
[2]	Lyu Yan, Yang Yida. Medical management of patients with primary biliary cholangitis [J]. Journal of Practical Hepatology, 2021, 24(6): 772-775.
[3]	Xing Li, Du Qianying, Jiang Yanli, et al. Impact of segmented injection of contrast agent on hepatic vein imaging by CT angiography in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(6): 871-874.
[4]	Wu Huijuan, He Nian'an, Xie Li, et al. Contrast-enhanced ultrasonography and serum CA19-9 levels in differential diagnosis of patients with intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2021, 24(6): 903-906.
[5]	Zhou Zheng, Liu Wei. Contrast-enhanced ultrasound features of hepatic hemangioma, hepatocellular carcinoma and hepatic angiomyolipoma [J]. Journal of Practical Hepatology, 2021, 24(6): 911-914.
[6]	Wang Ligong, Zhao Shan, Bai Kai, et al. Serum α1 acidic glycoprotein, α1-antitrypsin and haptoglobin levels could be applied to predict hepatic fibrosis in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2021, 24(5): 673-676.
[7]	Zhou Bingqing, Yang Hanqing, Jiang Beili. Re-treatment of chronic hepatitis B non-responders to pegylated interferon-α by tenofovir and entecavir [J]. Journal of Practical Hepatology, 2021, 24(5): 681-684.
[8]	Yang Yonghan, Lu Ping, Meng Qingning, et al. Quantitative evaluation of hepatic fibrosis in patients with chronic hepatitis B by enhanced MRI T1 mapping [J]. Journal of Practical Hepatology, 2021, 24(5): 685-688.
[9]	Ge Haiyan, Kuang Xia, Zhou Ruijun. Changes of serum miR-17, miR-20a and miR-20b levels in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus [J]. Journal of Practical Hepatology, 2021, 24(5): 697-700.
[10]	Liang Xu, Liu Yuanyuan, Yang Xuegang, et al. Computed tomography and magnetic resonance imaging in the diagnosis of patients with hepatocellular carcinoma based on liver imaging report data system v2018 [J]. Journal of Practical Hepatology, 2021, 24(5): 725-728.
[11]	Zhang Wuhua, Li Hailong, Qin Qibin. Improved CT diagnosis of patients with hepatic hemangioma by automatic tube current modulation and adaptive statistical iterative reconstruction [J]. Journal of Practical Hepatology, 2021, 24(5): 749-752.
[12]	Xu Yan, Li Xiaotian, Liu Hui, et al. MRI features of patients with wall-thickening gallbladder carcinoma [J]. Journal of Practical Hepatology, 2021, 24(5): 757-760.
[13]	Sun Hairong, Feng Weiguang, Zhou Bingqing, et al. Liver stiffness measurement in patients with chronic hepatitis B viral infection and different alanine aminotransferase levels [J]. Journal of Practical Hepatology, 2021, 24(4): 488-491.
[14]	An Hongjie, Xu Jinfeng, Geng Hua, et al. Prediction of liver fibrosis by liver stiffness measurement andaspartate aminotransferase/platelet ratio in patients with chronic hepatitis C [J]. Journal of Practical Hepatology, 2021, 24(4): 492-495.
[15]	Wang Jia’ni, Liu Yong, Zhou Xin, et al. Predictive value of liver cirrhosis by serum microRNA-1273g-3p levels in patients with chronic hepatitis C [J]. Journal of Practical Hepatology, 2021, 24(4): 496-499.